Tirzepatide vs Retatrutide Research Comparison: What Australian Labs Are Studying in 2026

Tirzepatide and Retatrutide represent two of the most significant multi-agonist peptides in current metabolic research. As Australian laboratories intensify their focus on obesity, diabetes, and metabolic disorders, understanding the differences between these compounds is essential for designing effective experiments. This comprehensive comparison examines the science, mechanisms, and research applications of Tirzepatide and Retatrutide, with insights